Whiteside Hoyle L, Ratanapo Supawat, Nagabandi Arun, Kapoor Deepak
Division of General Internal Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA.
Division of Cardiology, Medical College of Georgia at Augusta University, Augusta, GA, USA.
Cardiovasc Revasc Med. 2018 Sep;19(6):660-665. doi: 10.1016/j.carrev.2018.02.008. Epub 2018 Feb 9.
Elective insertion of a percutaneous circulatory assist device (PCAD) in high-risk patients is considered a reasonable adjunct to percutaneous coronary intervention (PCI). There is limited data examining the safety and efficacy of rotational atherectomy (RA) without hemodynamic support in patients with reduced left ventricular ejection fraction (LVEF).
We retrospectively identified 131 consecutive patients undergoing RA without elective PCAD over a three-year period. Patients were categorized into three groups: LVEF ≤30%, LVEF 31-50%, and LVEF >50%. The incidence of procedural hypotension, major adverse cardiac events (MACE), and mortality were recorded.
Statistical analysis included 18, 42, and 71 patients with LVEF ≤30%, 31-50%, and >50%, respectively. Bailout hemodynamic support was required in four cases. Analysis revealed a significant trend as bailout hemodynamic support was required in 11.1% vs 2.4% (P = 0.1551) in the ≤30% vs 31-50% and 11.1% vs 1.4% (P = 0.0416) in the ≤30% vs >50% subgroups. Combined subgroup analysis also demonstrated statistical significance 11.1% vs 1.8% (P = 0.0324) in the ≤30% vs >30% subgroups. No-reflow phenomenon was more prevalent in patients with reduced LVEF (LVEF ≤30%: 11.1%, LVEF 31-50%: 2.4%, LVEF >50%: 0%; P = 0.0190). Otherwise, no significant differences in in-hospital MACE, or mortality were observed.
RA can be effectively utilized in patients with severely reduced LVEF; however, these patients are at increased risk of prolonged procedural hypotension requiring bailout hemodynamic support. If indicated, prompt implementation of hemodynamic support mitigated any impact of procedural hypotension on in-hospital MACE and mortality.
在高危患者中选择性植入经皮循环辅助装置(PCAD)被认为是经皮冠状动脉介入治疗(PCI)的合理辅助手段。关于左心室射血分数(LVEF)降低的患者在无血流动力学支持情况下进行旋磨术(RA)的安全性和有效性的数据有限。
我们回顾性确定了连续三年中131例未接受选择性PCAD而接受RA的患者。患者分为三组:LVEF≤30%、LVEF 31 - 50%和LVEF>50%。记录手术中低血压、主要不良心脏事件(MACE)和死亡率的发生率。
统计分析分别纳入了18例、42例和71例LVEF≤30%、31 - 50%和>50%的患者。4例患者需要补救性血流动力学支持。分析显示存在显著趋势,≤30%组与31 - 50%组相比,需要补救性血流动力学支持的比例为11.1%对2.4%(P = 0.1551),≤30%组与>50%组相比为11.1%对1.4%(P = 0.0416)。联合亚组分析在≤30%组与>30%组中也显示出统计学意义,为11.1%对1.8%(P = 0.0324)。LVEF降低的患者无复流现象更常见(LVEF≤30%:11.1%,LVEF 31 - 50%:2.4%,LVEF>50%:0%;P = 0.0190)。否则,在院内MACE或死亡率方面未观察到显著差异。
RA可有效用于LVEF严重降低的患者;然而,这些患者出现手术中低血压持续时间延长并需要补救性血流动力学支持的风险增加。如果有指征,及时实施血流动力学支持可减轻手术中低血压对院内MACE和死亡率的任何影响。